LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners.

    Wollen, Keith A

    Alternative medicine review : a journal of clinical therapeutic

    2010  Volume 15, Issue 3, Page(s) 223–244

    Abstract: Alzheimer's disease (AD) is characterized by dysfunctional intracellular and extracellular biochemical processes that result in neuron death. This article summarizes hypotheses regarding cell dysfunction in AD and discusses the effectiveness of, and ... ...

    Abstract Alzheimer's disease (AD) is characterized by dysfunctional intracellular and extracellular biochemical processes that result in neuron death. This article summarizes hypotheses regarding cell dysfunction in AD and discusses the effectiveness of, and problems with, different therapies. Pharmaceutical therapies discussed include cholinesterase inhibitors, memantine, antihypertensive drugs, anti-inflammatory drugs, secretase inhibitors, insulin resistance drugs, etanercept, brain-derived neurotrophic factor, and immunization. Nutritional and botanical therapies included are huperzine A, polyphenols, Ginkgo, Panax ginseng, Withania somnifera, phosphatidylserine, alpha-lipoic acid, omega-3 fatty acids, acetyl L-carnitine, coenzyme Q10, various vitamins and minerals, and melatonin. Stimulatory therapies discussed are physical exercise, cognitive training, music, and socialization. Finally, treatment strategies are discussed in light of the benefits and drawbacks of different therapeutic approaches. It is concluded that potential risks of both approved and non-approved therapies should be weighed against the potential benefits and certain consequences of disease progression. Approaches that target several dysfunctions simultaneously and that emphasize nutritional, botanical, and stimulatory therapies may offer the most benefit at this time.
    MeSH term(s) Alzheimer Disease/prevention & control ; Alzheimer Disease/therapy ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Antioxidants/therapeutic use ; Chelating Agents/therapeutic use ; Combined Modality Therapy ; Dietary Supplements ; Exercise ; Fatty Acids, Omega-3/therapeutic use ; Humans ; Minerals/therapeutic use ; Music Therapy/methods ; Neuroprotective Agents/therapeutic use ; Phytotherapy/methods ; Plant Extracts/therapeutic use ; Plants, Medicinal ; Social Support
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Antioxidants ; Chelating Agents ; Fatty Acids, Omega-3 ; Minerals ; Neuroprotective Agents ; Plant Extracts
    Language English
    Publishing date 2010-09
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1465535-4
    ISSN 1089-5159
    ISSN 1089-5159
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.

    Bornholdt, Zachary A / Turner, Hannah L / Murin, Charles D / Li, Wen / Sok, Devin / Souders, Colby A / Piper, Ashley E / Goff, Arthur / Shamblin, Joshua D / Wollen, Suzanne E / Sprague, Thomas R / Fusco, Marnie L / Pommert, Kathleen B J / Cavacini, Lisa A / Smith, Heidi L / Klempner, Mark / Reimann, Keith A / Krauland, Eric / Gerngross, Tillman U /
    Wittrup, Karl D / Saphire, Erica Ollmann / Burton, Dennis R / Glass, Pamela J / Ward, Andrew B / Walker, Laura M

    Science (New York, N.Y.)

    2016  Volume 351, Issue 6277, Page(s) 1078–1083

    Abstract: Antibodies targeting the Ebola virus surface glycoprotein (EBOV GP) are implicated in protection against lethal disease, but the characteristics of the human antibody response to EBOV GP remain poorly understood. We isolated and characterized 349 GP- ... ...

    Abstract Antibodies targeting the Ebola virus surface glycoprotein (EBOV GP) are implicated in protection against lethal disease, but the characteristics of the human antibody response to EBOV GP remain poorly understood. We isolated and characterized 349 GP-specific monoclonal antibodies (mAbs) from the peripheral B cells of a convalescent donor who survived the 2014 EBOV Zaire outbreak. Remarkably, 77% of the mAbs neutralize live EBOV, and several mAbs exhibit unprecedented potency. Structures of selected mAbs in complex with GP reveal a site of vulnerability located in the GP stalk region proximal to the viral membrane. Neutralizing antibodies targeting this site show potent therapeutic efficacy against lethal EBOV challenge in mice. The results provide a framework for the design of new EBOV vaccine candidates and immunotherapies.
    MeSH term(s) Animals ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/isolation & purification ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Neutralizing/chemistry ; Antibodies, Neutralizing/isolation & purification ; Antibodies, Neutralizing/therapeutic use ; Antibodies, Viral/chemistry ; Antibodies, Viral/isolation & purification ; Antibodies, Viral/therapeutic use ; Antibody Formation ; Antigen-Antibody Complex/chemistry ; Democratic Republic of the Congo/epidemiology ; Disease Outbreaks ; Ebola Vaccines/immunology ; Ebola Vaccines/therapeutic use ; Ebolavirus/immunology ; Hemorrhagic Fever, Ebola/epidemiology ; Hemorrhagic Fever, Ebola/immunology ; Hemorrhagic Fever, Ebola/therapy ; Humans ; Immunization, Passive ; Mice ; Survivors ; Tissue Donors ; Viral Envelope Proteins/chemistry ; Viral Envelope Proteins/immunology ; Virion/immunology
    Chemical Substances Antibodies, Monoclonal ; Antibodies, Neutralizing ; Antibodies, Viral ; Antigen-Antibody Complex ; Ebola Vaccines ; Viral Envelope Proteins ; envelope glycoprotein, Ebola virus
    Language English
    Publishing date 2016-03-04
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.aad5788
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top